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ABSTRACT 
Infertility is defined as inability of a couple to conceive after one year of regular unprotected 
sexual intercourse. Incidence of ovarian dysfunction in the form of Polycystic ovarian disease 
(PCOD) has become a leading cause of female infertility in today’s era. Polycystic Ovarian 
disease (PCOD) is a heterogeneous, multifactorial and polygenic endocrinal disorder. Acharya 
Sushrut explained about Bandhya Yonivya pada where Nashtartava is mentioned as the one and 
only symptom. In Ayurveda text word Aartava has been used extensively in different contexts; 
menstrual blood, ovum and ovarian hormones. Therefore Amenorrhea, anovulation, hormonal 
dysfunction can be considered as visible manifestations of Nashtartva. So, here an attempt has 
been made to explore Samshodhan (Virechan) as a possible line of treatment for Bandhya 
(Nashtartava). Material and method: Following is a case report of a female who was anxious 
to conceive after 4 years of active married life, along with H/O delayed menses.  Her USG 
reports showed polycystic appearance of ovaries and anovulation was noticed in follicular 
study. During this case study evaluation of Shodhan therapy (Virechan) and Shaman therapy in 
infertility due to ovulatory dysfunction was done. Result: Before the treatment patient was a 
known case of infertility due to PCOD and after treatment she conceived and delivered a healthy 
female baby. Discussion: Line of treatment was to enhance potency of ovum and with the help 
of Virechankarma, regularize vitiated Vata Dosha, Shrotoshuddhi and Aartava janan. 
Conclusion: Ayurveda therapy can be used in patients of infertility due to PCOD for better 
outcome and no adverse drug effect was noticed. 
KEYWORDS Bandhya, Nashtartva, Female Infertility, Ovarian Factor PCOD, Samshodhan, 
Virechan. 
INTRODUCTION 
 According to Ayurveda the four main factors 
responsible for the proper conception[1] are 
described as Garbh sambhav samagri; Ritu (Fertile 
period), Kshetra (Fertile uterus), Ambu (nutrition) 
and Beeja (viable Ovum and Sperm). Absence or 
abnormality in any of the above factors may result in 
infertility. Here Beeja can be referred as healthy 
ovum and sperm. While talking about of female 
infertility, Beeja dushti can be considered as 
ovulatory dysfunction; anovulation. Thus, it is seen 
that anovulation is an important factor causing 
infertility as per Ayurveda. 
According to WHO Infertility is a disease of 
the reproductive system in which there is a failure to 
achieve a clinical pregnancy after 12 months or more 
of regular unprotected sexual intercourse.  This is a 
multifactorial disease; ovarian, cervical, tubal and 
endometrial factors are responsible for female 
infertility, where ovarian factor causes maximum 
(30-40%) contribution[2].  
In ovulatory factors PCOD stands on first 
place as 90–95% of anovulatory women seeking 
treatment for infertility have PCOD.[3] 
Polycystic ovary syndrome (PCOS) a 
heterogeneous, multifactorial endocrine disorder and 
its prevalence is approximately 5.5-19.9%.[4] For the 
diagnosis of PCOS ESHRE/ ASRM Rotterdam criteria 
are available according to that, a woman must have at 
least two of three criteria after other related health 
conditions are ruled out: oligo-ovulation and/or 
anovulation, clinical and/or biochemical signs of 
hyper- androgenism, and polycystic ovary- is visible 
by ultrasound[5,6].  
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  Acharya Sushruta mentioned Nashtartava as a 
cardinal symptom of Bandhya Yonivyapada. After 
discussing about of Asthaartva- dushthi, Nashtartava 
has been explained separately. In which Artava is not 
destroyed completely but it is not evident due to 
obstruction of its channels, as the passage is enclosed 
by Vata and Kapha and ultimately it results in 
amenorrhoea. In this particular case if we 
hypothesize Aartava as ovum then we can consider 
Nastartarva as anovulation which is an important 
cause of infertility.  
Case Report 
A female of 29 years came to Prasuti and Striroga 
OPD (registration no.10347/26-02-2020) of primary 
infertility and anxious for conception.  
Menstrual History: L.M.P- 22/02/2019, 3-4/40-45 
days, delayed menses, moderate flow sometimes with 
clots, painless. 
H/O present illness: K/C/O PCOS for 8 years, was 
treated by different treatment modalities; Allopathy 
and Ayurveda as well management for delayed 
menses when she was unmarried. After active 
married life of 4 years her USG report was suggestive 
of polycystic appearance of ovaries and in follicular 
study anovulation was noticed. She took ovulation 
induction drugs, hormonal pills. After 2 year of active 
married life she was advised to go for diagnostic 
hystero laparoscopy, HSG, and IUI twice but with the 
failure she finally came to our OPD of Prasuti & 
Striroga at Dr.S.R.Rajasthan Ayurveda University, 
Jodhpur.  
Personal history: Occupation: Ayurveda doctor 
Appetite: good 
Sleep: disturbed some times 
Bowel: constipated some times 
Bladder: clear  
Psychological status: stressed and anxious 
Husband- occupation: Allopathy doctor, addiction: 
alcohol some times 
O/E: B.P- 120/80 mm of hg, Ht- 157cm, Wt.- 65 kg 
P/A– soft no palpable mass, no tenderness, P/S- 
healthy cervix, P/V – uterus AVAF, cervical motion 
non-tender. 
Investigations 
Male partner- Semen analysis (24/08/2016)- Vol- 
2ml, Count- 103.6million/ml, Motility-70-75%, 
sluggish- 15-20%, normal morphology. 
Female partner- Haemogram- WNL, ESR-12.7mm/hr, 
HIV, HBsAg, VDRL – non-reactive, RBS- 91mg/dl, LFT, 
RFT & Lipid Profile - WNL. MT –Negative, TSH- 1.64 
mcIU/ml, LH- 10.6mIU/ml, S. prolactin – 8.89mg/ml, 
S. FSH was not mentioned in any of her repots so as 
the ratio was being not mentioned in this case report, 
although it is also an important diagnostic tool for 
PCOS. 
USG (28/07/2016)- B/L PCO 
Follicular monitoring- TVS 
(11/12/2017) to 16/12/2017–stimulated, LMP– 
3/12/2017, on 16th day no dominant follicle was seen 
(10/01/2018)- stimulated (letroz2.5 & FSH 150), 
LMP – 01/01/2018, on 15th day- no dominant follicle 
was seen. 
Diagnostic hysteroscopy & laparoscopy 
(12/02/2018)- Impression- B/L patent fallopian 
tubes, PCOD. 
IUI- 14/03/2018– first cycle, 25/05/2018– second 
cycle. 
In this particular case semen analysis of male 
partner was absolutely normal so after excluding that 
factor we focused on female partner. It was observed 
that patient was having anovulation as a foremost 
cause of infertility as her other reports were normal. 
In her follicular monitoring, even after stimulation 
with the help of ovulation induction drugs there was 
no dominant follicle for two consecutive cycles. She 
also undergone IUI twice but that was failed 
repeatedly. After detailed history taking and 
observing previous reports it was very clear that 
ovum was not formed properly so as the ovulation. 
  Line of treatment– Samshodhan karma 
(purification therapy) was opted as a first line of 
treatment after analyzing the condition. According to 
Acharya Dalhan in case of Aartava dushthi 
purification should be only in form of Vamana, not 
Virechana. As in Virechana Pitta is reduced which 
results in Aartvakashya. But Acharya Chakrapani says 
that use of both purification measures clears upward 
and downward channel respectively[7]. By Virechan 
karma specifically vitiated Pitta will be evacuated so 
it will actually purify and clear the channels by 
removing obstructions and enhance the quality of 
Aartava. In Virechan karma there is downwards 
evacuation of Doshas so it will also help to regulate 
Apan vayu gati. Aacharya Kashyap has also 
mentioned that with the help of Virechan karma 
potency of Beeja enhances[8].  
 Treatment 
1. First visit– on 26/02/2019, LMP- 22/02/2019, 
patient was not on any of Allopathy drugs. 
2. Kunjal kriya on 27/02/2019, 1/03/2019 and 
4/03/2019 
3. Deepen paachan with Ajmodadi choorna started 
from 5/03/2019 to 11/03/2019 
4. Second visit- Virechan karma was planned- 
patient was admitted with IPD no. 517/12865 
(12/03/2019) 
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S.no.  Date  Procedure Drug and dose  Anupaan & kaal 
1.  12/03/2019 Sneh paan  (Phalghrita)-  
day 1=30ml, day 2=60ml, day 
3= 100ml, day 4= 160ml 
Lukewarm water, empty 
stomach early morning 
2.  16/03/2019 Abhyanga & 
Swedan 
Til taila, for 3 days (on the day 
of Virechan included) 
 
3.  18/03/2019 Virechan  Trivrita avaleh (60gm) Lukewarm water 
10:00am  
By Virechan karma Madhyam shuddhi was achieved. 
Patient was advised to follow Samsarjan karma for 2 
Annakal/ 5 days. 
Third visit– 06/04/2019 registration no. (16078), 
LMP – 03/04/2019 
Shatavari choorna – 3gm + Pushpdhanwa ras – 
250mg + Lakshmana lauh 250mg BD, after meal 
Avipattikar choorna 3gm + Shankha bhasm 250mg – 
before meal, BD, with Kaanchnaar gugglu 2 tab 
empty stomach. 
Follow-up- she was explained about fertile period, 
advised to do meditation. 
OBSERVATION AND RESULT  
After one month when she missed her period and her 
UPT was positive. 
USG- 28/05/2019- early intra uterine pregnancy of 5 
week 6 days with normal foetal cardiac activity. EDD 
– 22/01/2020 
DISCUSSION 
In the present case report, according to the 
history and clinical examination it was considered as 
a case of Vandhyatva due to Nashtartava, Artava 
vaha-shrotorodha and Apan vata vaigunya. In this 
case of infertility anovulation was the main cause. All 
menstrual disorders including anovulation are the 
result of vitiated Asruk/Artava. Nashtartava/ 
Nishphal aartav is caused by obstruction of Artavavah 
srotas by vitiated Kapha and Vatadosha. For 
clearance of this Srotorodha and thus maintenance of 
regular menstrual cycle Shodhan in form of Virechan 
and Shaman therapy was planned. 
1. Kunjalkriya – It mainly acts on Aamashaya, cleans 
digestive system from mouth to stomach, removes 
excess Amashayasth vitiated Kapha, pacifies 
Samanvayu and hence proper metabolism is 
maintained. 
2. Deepen, Paachana helps in preventing the 
production of Ama and vitiation of Dosha and 
Dhatu can be reduced.  
3. Virechan– Shodhan karma is suggested as the line 
of treatment for menstrual and other 
gynecological disorders[9], Virechan karma is one 
of the frequently opted choices because of its wide 
applicability and simplicity. By having dominion 
effect on Pitta and Agni it pacifies vitiated Pitta, 
does cure Asruk/Artava vikar, does detoxification 
and clearance of Aartava-vaha-srotas. Virechan 
enhances potency of Shukra, shukra- Vyadhiharam, 
Apatyam, Vrushataa, balam etc are some benefits 
can be achieved with the help of Virechana 
karma.[10] 
4. Shatavari choorna– It is considered as a female 
tonic in Ayurveda and also beneficial in female 
infertility[11], as it enhances folliculo-genesis and 
ovulation, prepares the womb for conception, and 
prevents miscarriages[12].  
5. Pushpadhanva Rasa–Chief ingredients of this 
drugs are having properties; Dhatu vridhikar, 
Agnidiptikar, Vaajikaran. Dhatura, BhIanga, 
Ngavalli etc., are having stimulant effect over 
Neuro-endocrinal system.  It is given in condition 
as amenorrhea or anovulation. It contains mineral 
drugs which have activities like- Rasayana, 
Yogavahi, Aartava janana properties along with 
Tridosha har and Kapha-Vata shamak property.  
6. Lakshmana lauh– It is said to have properties; 
Balya, Vaajikaran and Vrishya. 
7. Avipattikar choorna helped to regularize normal 
functions of liver and thus enhancing Kayagni and 
Dhatwagni.[13] 
8. Kanchnar helps to remove blockage in the 
channels and also works on polycystic ovary due 
to Kaphanasak and Granthihar property[14].  
CONCLUSION  
  PCOS is an increasing public health problem 
which is very common and leading cause of infertility 
in women. In this particular disease anovulation or 
Aartava-dushthi plays a crucial role in developing 
pathogenesis. Virechana is a process of Srotoshodhan 
(Biopurification), Detoxification, and it also enhances 
potency of Stree shukra thus, helps in Samprapti 
vighatan. After eliminating Doshas from their roots 
patient was treated with Aartavajanan, Vaajikaran, 
Vata-kaphnaashak, Dhatwagnivardhak, and Granthi 
har drugs. By all the above-mentioned measures, 
patient conceived and delivered a healthy child. No 
adverse effect was noticed so, more studies should be 
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conducted to explore role of Virechan karma in 
infertility due to ovarian dysfunction. 
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